Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Massachusetts Eye and Ear Infirmary - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013181
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Massachusetts Eye and Ear Infirmary (MEE) is a healthcare service provider that offers primary, medical and surgical care services. The hospital offers services through departments such as ophthalmology, otolaryngology and patient care services. Its patient care services include patient education, social work, nursing, one medical passport, adult surgical, pediatric surgical, anesthesia and surgery, radiology, audiology hearing and medical unit services. MEE’s ophthalmology services consists of ophthalmology and cataract, optometry and contact lens service, cornea and refractive surgery, diabetic eye disease, glaucoma, neuro-ophthalmology, ocular immunology, pediatric ophthalmology and strabismus, laser vision correction and vision rehabilitation. The hospital provides research and educational services. MEE is headquartered in Boston, Massachusetts, the US.

Massachusetts Eye and Ear Infirmary – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Massachusetts Eye and Ear Infirmary, Medical Devices Deals, 2011 to YTD 2017 9
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
NeoStem Enters into Research Agreement with Massachusetts Eye and Ear Infirmar and Schepens Eye Research Institute 11
Massachusetts Eye & Ear And Joslin Diabetes Center Partner For Eye Care 12
Licensing Agreements 13
Vivet Therapeutics Enters into Licensing Agreement with Fundacion para la Investigacion Medica Aplicada and Massachusetts Eye and Ear 13
Selecta Biosciences Enters into Licensing Agreement with Massachusetts Eye and Ear Infirmary 14
ONL Therapeutics Enters Into Licensing Agreement with University Of Michigan and Massachusetts Eye and Ear Infirmary 15
Massachusetts Eye and Ear Infirmary – Key Competitors 16
Massachusetts Eye and Ear Infirmary – Key Employees 17
Massachusetts Eye and Ear Infirmary – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Government and Public Interest 20
Aug 21, 2017: Massachusetts Eye and Ear: Researchers identify key compounds to resolve abnormal vascular growth in age-related macular degeneration 20
Apr 01, 2016: Researchers identify candidate biomarker of accelerated onset diabetic retinopathy 22
Mar 03, 2016: New research links mitochondrial dysfunction to the development of FECD 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare, Key Facts 2
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Massachusetts Eye and Ear Infirmary, Deals By Therapy Area, 2011 to YTD 2017 8
Massachusetts Eye and Ear Infirmary, Medical Devices Deals, 2011 to YTD 2017 9
Massachusetts Eye and Ear Infirmary, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
NeoStem Enters into Research Agreement with Massachusetts Eye and Ear Infirmar and Schepens Eye Research Institute 11
Massachusetts Eye & Ear And Joslin Diabetes Center Partner For Eye Care 12
Vivet Therapeutics Enters into Licensing Agreement with Fundacion para la Investigacion Medica Aplicada and Massachusetts Eye and Ear 13
Selecta Biosciences Enters into Licensing Agreement with Massachusetts Eye and Ear Infirmary 14
ONL Therapeutics Enters Into Licensing Agreement with University Of Michigan and Massachusetts Eye and Ear Infirmary 15
Massachusetts Eye and Ear Infirmary, Key Competitors 16
Massachusetts Eye and Ear Infirmary, Key Employees 17
Massachusetts Eye and Ear Infirmary, Other Locations 18

★海外企業調査レポート[Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PetSmart Inc:企業の戦略・SWOT・財務分析
    PetSmart Inc - Strategy, SWOT and Corporate Finance Report Summary PetSmart Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Mckinsey & Company, Inc.
    Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Orvana Minerals Corporation:企業の戦略・SWOT・財務情報
    Orvana Minerals Corporation - Strategy, SWOT and Corporate Finance Report Summary Orvana Minerals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • EIH Limited:戦略・SWOT・企業財務分析
    EIH Limited - Strategy, SWOT and Corporate Finance Report Summary EIH Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Samsung Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務分析
    Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Pfenex Inc (PFNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple scl …
  • XCyton Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary XCyton Diagnostics Ltd (Xcyton) is a molecular biology company that develops and markets diagnostics products and services. The company provides ELISA kit for the detection of HIV infection; ELISA products for the detection of Neurocysticercosis, Hepatitis C and Japanese encephalitis. It pro …
  • 23andMe Inc-医療機器分野:企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • Wireless Group Limited:企業の戦略的SWOT分析
    Wireless Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Main Street America Insurance Company:企業の戦略的SWOT分析
    Main Street America Insurance Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • Blue Cross and Blue Shield Association:企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Lidco Group Plc (LID):企業の財務・戦略的SWOT分析
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic monitoring equipment. The company offers products such as LiDCOrapid, LiDCOunity, LiDCOplus, LiDCOview and LiDCOaccessories . Its LiDCOplus is a computer-based platform monitor, which is used in the intensive care …
  • CONSOL Energy Inc.:企業のM&A・事業提携・投資動向
    CONSOL Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CONSOL Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Euroimmun AG:医療機器:M&Aディール及び事業提携情報
    Summary Euroimmun AG (Euroimmun), a subsidiary of PerkinElmer Inc is a medical device company that provides automation products. The company offers products such as indications, technical IIFT products, and automations. Its indications comprise auto-immune encephalitis, auto antibodies, anti-NMDA re …
  • National Power Corporation:企業の戦略的SWOT分析
    National Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Swarovski AG:企業の戦略・SWOT・財務分析
    Swarovski AG - Strategy, SWOT and Corporate Finance Report Summary Swarovski AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Swiss Life Holding Ltd:企業のM&A・事業提携・投資動向
    Swiss Life Holding Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Life Holding Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Larix AS-製薬・医療分野:企業M&A・提携分析
    Summary Larix A/S (Larix) is a contract research organization that offers services related to clinical trials assistance. The company provides services such as statistics, data management, clinical research, pharmacovigilance and data monitoring among others. It offers services across all phases of …
  • Ezaki Glico Co Ltd:企業の戦略・SWOT・財務分析
    Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆